论文部分内容阅读
目的:探讨氯吡格雷联合阿司匹林和尿激酶治疗急性ST段抬高型心肌梗死的临床疗效。方法:选取72例急性ST段抬高型心肌梗死患者,将其随机分为观察组与对照组。对照组给予常规的阿司匹林治疗和尿激酶溶栓治疗,观察组在此基础上给予氯吡格雷治疗。结果:观察组完全性STR者占66.67%,明显高于对照组的47.22%(P<0.05);观察组无明显STR者占11.11%,明显低于对照组的25.00%(P<0.05)。观察组复合终点的有2例(占5.56%),明显低于对照组的8例(占22.22%)(P<0.05)。结论:氯吡格雷联合阿司匹林和尿激酶治疗急性ST段抬高型心肌梗死临床疗效显著,值得推广。
Objective: To investigate the clinical efficacy of clopidogrel combined with aspirin and urokinase in the treatment of acute ST-segment elevation myocardial infarction. Methods: Seventy-two patients with acute ST-segment elevation myocardial infarction were randomly divided into observation group and control group. The control group was given conventional aspirin and urokinase thrombolysis, and the observation group was given clopidogrel on this basis. Results: The complete STR in the observation group accounted for 66.67%, which was significantly higher than that in the control group (47.22%, P <0.05). There was no significant STR in the observation group (11.11%), which was significantly lower than that in the control group (25.00%, P <0.05). There were 2 cases (5.56%) in the observation group and 8 cases (22.22%) in the control group (P <0.05). Conclusion: Clopidogrel combined with aspirin and urokinase in the treatment of acute ST-segment elevation myocardial infarction has obvious curative effect and is worth popularizing.